View Post

Enrollment Begins In ONC201 Clinical Trial Expansion Phase

In In The News by Barbara Jacoby

Hummelstown, PA – Oncoceutics, Inc. announced that the first patients have been enrolled in the expansion phase of the first-in-man clinical trial with C201 at the Rutgers Cancer Institute of New Jersey (CINJ).  Previously, Oncoceutics reported the completion of the dose escalation portion of the trial entitled “Oral ONC201 in Treating Patients with Advanced Solid Tumors” and identified as NCT02250781 …

View Post

For Cancer-Detecting Canines, The Nose Knows

In In The News by Barbara Jacoby

From: npr.org. A new clinical trial is set to begin in the United Kingdom using the powerful noses of dogs to detect prostate cancer in humans. While research has been done before, these are the first trials approved by Britain’s National Health Service. The trials, at the Milton Keynes University Hospital in Buckinghamshire, will use animals from a nonprofit organization …

View Post

Drug could help slow half of breast cancers, study suggests

In In The News by Barbara Jacoby

By: James Gallagher From: bbc.com A cheap and safe drug could help half of women with breast cancer to live longer, scientists suggest. Their study, published in Nature, is in its early stages, but hints that the hormone progesterone could be used to slow the growth of some tumours. The UK and Australian researchers say the findings are “very significant” …

View Post

A “Knock-Out” Targeted Therapy May Shrink Tumors, Extend Lives of Patients with Metastatic Lung Cancer, Reports Christiana Care Health System Oncologist at ASCO

In In The News by Barbara Jacoby

New antibody drug combination to treat patients with advanced lung cancer fast-tracked by FDA Clinical trial investigations of a targeted therapy called sacituzumab govitecan demonstrated promising anti-tumor activity in patients with hard-to-treat, metastatic lung cancer, according to results presented by Michael J. Guarino, M.D., a medical oncologist at Christiana Care’s Helen F. Graham Cancer Center & Research Institute, during the 2015 Annual …

View Post

Research grants awarded to SA’s Cancer Therapy and Research Center

In In The News by Barbara Jacoby

By: Ursula Pari From: ksat.com The Cancer Prevention and Research Institute of Texas just gave a jump start to a number of researchers at the Cancer Therapy and Research Center, including a $2 million grant for promising brain cancer radiation therapy. It uses nano-technology to help deliver large doses of tumor-shrinking radiation to the brain, without affected normal brain tissue …

Personalized vaccines, next frontier in cancer treatment, to begin clinical trial

In In The News by Barbara Jacoby

By: Amy Ellis Nutt From: washingtonpost.com In one of the first trials of personalized vaccines for cancer, the European-funded Glioma Actively Personalized Vaccine Consortium (GAPVAC) is about to launch a Phase 1 clinical trial for patients with glioblastoma, the most aggressive of brain cancers. The goal of nearly all cancer treatments is honing in on antigens, the target structures on tumors, …

Man Survives Rare Cancer Thanks to New ‘Targeted’ Therapy

In In The News by Barbara Jacoby

By LIZ NEPORENT From: abcnews.go.com James “Rocky” Lagno was so sick that doctors only gave him about a year to live. Having been diagnosed with late-stage lung cancer, even aggressive chemotherapy and radiation didn’t prevent the New Hampshire native’s tumors from growing larger. To top it off, he was also diagnosed with thyroid cancer and then, several months later, an …

Walter Reed Bethesda Joins Novilase Clinical Trial

In In The News by Barbara Jacoby

Groundbreaking Study of Laser Treatment for Breast Cancer Now Has 11 Active Trial Sites in United States and United Kingdom Novian Health, developer of Novilase® Breast Therapy, announced today that Walter Reed National Military Medical Center (Bethesda, Md.) is now a participating study site in the BR-002 Novilase Clinical Trial.  The multi-center study is evaluating the effectiveness of Novilase Breast …

Trials let more patients get ‘breakthrough’ cancer therapies closer to home

In In The News by Barbara Jacoby

By: Liv Osby From: greenvilleonline.com Rhonda McNeely will never forget that November day she had to tell her children she had advanced cancer. “When you have to come home and tell your daughters that you have cancer,” she said, “the looks in their eyes … it was a very sobering thing for all of us.” If there was any ray …

Trial to see how personalised treatment can fight cancer set to begin this year

In In The News by Barbara Jacoby

From: Press Association – theguardian.com A drugs trial designed to discover how personalised treatment can help in the fight against cancer begins later this year. Cancer Research UK has joined forces with pharmaceutical companies AstraZeneca and Pfizer to create a pioneering clinical trial for patients who have advanced lung cancer, the UK’s biggest cancer killer. Scientists from Cancer Research UK …